Theravance Biopharma, Inc. Indenture Agreements
3 Contracts & Agreements
- THERAVANCE BIOPHARMA, INC. 3.25% CONVERTIBLE SENIOR NOTES DUE 2023 FIRST SUPPLEMENTAL INDENTURE DATED AS OF NOVEMBER 2, 2016 WELLS FARGO BANK, NATIONAL ASSOCIATION AS TRUSTEE (Filed With SEC on November 2, 2016)
- THERAVANCE BIOPHARMA, INC. 3.25% CONVERTIBLE SENIOR NOTES DUE 2023 FIRST SUPPLEMENTAL INDENTURE DATED AS OF NOVEMBER 2, 2016 WELLS FARGO BANK, NATIONAL ASSOCIATION AS TRUSTEE (Filed With SEC on November 2, 2016)
- THERAVANCE BIOPHARMA, INC. as Issuer and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee Trustee Indenture Dated as of November 2, 2016 (Filed With SEC on November 2, 2016)
